All lobbying filings

NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for THE ALLIANCE FOR LONGEVITY INITIATIVES · Advancing policies to increase a healthy human lifespan.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Feb 3, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.

Budget/Appropriations

Increased funding for longevity research at the National Institutes of Health

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.